10 clinical trials to watch in the second half of 2023
Restor3d inks Conformis buyout, adding hip and knee implants to portfolio
AstraZeneca sows $400M investment in push to plant 200M trees by 2030
What will AbbVie buy next?
*please scroll down for all the latest news*
